CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ( XRTX ) (“XORTX” or the “Company”) , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has entered into a binding term sheet (the “Term Sheet”) to acquire a Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CCLA Investment Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

Acquisition to expand the neuromodulation offerings for people living with chronic pain MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic pain. Boston Scientific (...

(Reuters) -SLB beat Wall Street estimates for third-quarter profit on Friday, helped by strong demand for its oilfield equipment and services in North America. The company reported an adjusted profit of 69 cents per share for the quarter ended September 30, compared with analysts' estimate of 66 cents, according to data compiled by LSEG. Quarterly revenue from its North America...